Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection
Margherita Rosati, Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 232
SARS-CoV-2: Evolution and Emergence of New Viral Variants
Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 653-653
Open Access | Times Cited: 85
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
Jan Van Elslande, Matthijs Oyaert, Natalie Lorent, et al.
Diagnostic Microbiology and Infectious Disease (2022) Vol. 103, Iss. 1, pp. 115659-115659
Open Access | Times Cited: 73
Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection
Costanza Di Chiara, Anna Cantarutti, Paola Costenaro, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2221616-e2221616
Open Access | Times Cited: 52
Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
Charalampos Filippatos, Ioannis Ntanasis‐Stathopoulos, Kalliopi Sekeri, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 765-765
Open Access | Times Cited: 16
Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates
Kristin A. Sauter, Gabriela M Webb, Lindsay Bader, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection
Eva‐Maria Jacobsen, Dorit Fabricius, Magdalena Class, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 years after COVID-19 infection
Mariam Movsisyan, Nune Truzyan, И. Э. Каспарова, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
A stronger antibody response in increased disease severity of SARS-CoV-2
Marta Iglis de Oliveira, Melayne Rocha Aciole, Patrícia Areias Feitosa Neves, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics
J Zhang
Heliyon (2024) Vol. 10, Iss. 14, pp. e34577-e34577
Open Access | Times Cited: 3
Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom’s Macroglobulinemia after BNT162b2 Booster Vaccination
Margherita Rosati, Evangelos Terpos, Jenifer Bear, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5816-5816
Open Access | Times Cited: 16
The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the Omicron variant in children 5 to 11 years of age
Bianca Laura Cinicola, Eva Piano Mortari, Anna Maria Zicari, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies
Cristina Bergamaschi, Maria Pagoni, Margherita Rosati, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Determinants of Anti-S Immune Response at 12 Months after SARS-CoV-2 Vaccination in a Multicentric European Cohort of Healthcare Workers—ORCHESTRA Project
Ludovica Leomanni, Giulia Collatuzzo, Emanuele Sansone, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1527-1527
Open Access | Times Cited: 7
Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations
Margherita Rosati, Evangelos Terpos, Philip Homan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination
Miao Wang, Bing Zhou, Qing Fan, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Gold Nanoparticle Virus-like Particles Presenting SARS-CoV-2 Spike Protein: Synthesis, Biophysical Properties and Immunogenicity in BALB/c Mice
Vivian A. Salazar, Joan Comenge, Rosa Suárez-López, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 829-829
Open Access | Times Cited: 1
Longitudinal Randomized Cohort Study of SARS-CoV-2 Antibody Seroprevalence in the St. Petersburg Population
В. С. Смирнов, L. V. Lyalina, A. M. Milichkina, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 913-913
Open Access | Times Cited: 7
Antigen–Antibody Complex-Guided Exploration of the Hotspots Conferring the Immune-Escaping Ability of the SARS-CoV-2 RBD
Kit-Man Fung, Shu-Jung Lai, Tzu-Lu Lin, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 6
An adjusted ELISpot-based immunoassay for evaluation of SARS-CoV-2-specific T-cell responses
Hao Lin, Jie Zhang, Shaobo Dong, et al.
Biosafety and Health (2022) Vol. 4, Iss. 3, pp. 179-185
Open Access | Times Cited: 6
SARS-CoV-2 Reinfections: Overview of Efficacy and Duration of Natural and Hybrid Immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 5
ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis
Wisit Prasithsirikul, Tanawin Nopsopon, Phanupong Phutrakool, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 959-959
Open Access | Times Cited: 5
Characterizing Kinetics and Avidity of SARS-CoV-2 Antibody Responses in COVID-19 Greek Patients
Stavroula Labropoulou, Niki Vassilaki, Raphaela S. Milona, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 758-758
Open Access | Times Cited: 4
Evaluation of long-term antibody kinetics in healthcare workers vaccinated with inactivated COVID-19 Vero cell vaccine (CoronaVac), a propensity score-matched observational study
Yeşim Yıldız, Hasan Selçuk Özger, Esin Şenol, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 99-106
Open Access | Times Cited: 4
Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19
Wang-Da Liu, Jann‐Tay Wang, Tai‐Ling Chao, et al.
Journal of the Formosan Medical Association (2022) Vol. 122, Iss. 8, pp. 714-722
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top